exenatide vs semaglutide The structure of native GLP-1, exenatide, liraglutide, and Are GLP-1 diabetes drugs like

Vlainic, J., Vukelic, I., Perovic, D., et al

Retatrutide (pronounced reh-TAT-tru-tide) is a synthetic peptide-based therapy that activates three key hormone receptors involved in metabolism: GLP-1 receptor (Glucagon-Like Peptide-1) GIP receptor (Glucose-Dependent Insulinotropic Polypeptide) Glucagon receptor This makes Retatrutide a triple agonist a unique advancement over medications like semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro/Zepbound) , which activate only one or two of these receptors

The frequency and dosage can be tailored to the clients specific needs, with visible results often becoming apparent after several treatments

-